Pilot open label clinical trial with Abatacept in Ankylosing Spondylitis - ABATACEPT-AS-01
Pilot open label clinical trial with Abatacept in Ankylosing Spondylitis - ABATACEPT-AS-01
T cell responses have been demonstrated against proteoglycan (an important cartilage protein) in human arthritides including ankylosing spondylitis. We suggest that a chronic, probably T cell mediated, immune response against cartilage is relevant in the pathogenesis of AS.Based on the above described findings about the role of T-cells in ankylosing spondylitis we assume that Abatacept has the potential to be an effective drug for treating ankylosing spondylitis. T cell responses have been demonstrated against proteoglycan (an important cartilage protein) in hum ...
Trade Name: not applicable Product Name: Orencia Product Code: BMS-188667 INN or Proposed INN: Abatacept Other descriptive name: CTLA4IgTrade Name: not applicable Product Name: Orencia Product Code: BMS-188667 INN or Proposed INN: Abatacep ...